Nebulized Albuterol for Acute Hyperkalemia in Patients on Hemodialysis
Authors:
- Robert DunlayRDRobert Dunlay
- Charles CopkneyCCCharles Copkney
- 15 March 1989
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 110 (6) , 426-429
Abstract
To determine the efficacy and safety of nebulized albuterol in the acute treatment of hyperkalemia in patients on chronic hemodialysis. Prospective, double-blind, and placebo-controlled study. Outpatient hemodialysis clinic at a university medical center. Ten patients on maintenance hemodialysis who had chronic hyperkalemia. Patients received nebulized albuterol therapy (10 mg or 20 mg) or placebo (saline) on three separate occasions, serial measurements of plasma potassium levels, blood pressure, and pulse were then taken for a 2-hour period. Patients had a significant decrease in plasma potassium concentrations that was evident by 30 minutes and sustained for at least 2 hours after albuterol treatment. After the administration of 10- and 20-mg doses of albuterol, the maximal decrease in the plasma potassium levels was 0.62 +/- 0.09 and 0.98 +/- 0.14 mmol/L (SE), respectively. Nebulized saline administration did not produce a significant change in the plasma potassium concentrations. Patients did not develop symptoms or significant changes in blood pressure or heart rate with albuterol treatment. In the doses used, nebulized albuterol therapy resulted in a prompt and significant decrease in the plasma potassium concentrations in patients on hemodialysis, and caused no adverse cardiovascular effects. This treatment should be considered as an important adjunct for acute treatment of serious hyperkalemia in this population of patients.Keywords
This publication has 13 references indexed in Scilit:
- Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failureThe American Journal of Medicine, 1988
- Temporal Profile of Serum Potassium Concentration in Nondiabetic and Diabetic Outpatients on Chronic DialysisAmerican Journal of Nephrology, 1987
- Extrarenal potassium homeostasisKidney International, 1986
- HYPOKALAEMIA INDUCED BY INHALATION OF FENOTEROLThe Lancet, 1985
- Effects of Selective and Nonselective ??-Agonists on Plasma Potassium and NorepinephrineJournal of Cardiovascular Pharmacology, 1984
- Hypokalemia from Beta2-Receptor Stimulation by Circulating EpinephrineNew England Journal of Medicine, 1983
- Mortality Risk Factors in Patients Treated by Chronic HemodialysisNephron, 1982
- Reduced β‐adrenoceptor sensitivity in the elderlyClinical Pharmacology & Therapeutics, 1979
- Albuterol and Isoproterenol in Bronchial AsthmaArchives of internal medicine (1960), 1979
- The effect of catecholamines on Na—K transport and membrane potential in rat soleus muscleThe Journal of Physiology, 1977